TSS
BPMC

Two Sigma Securities’s Blueprint Medicines BPMC Stock Holding History

Two Sigma Securities’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,894
Closed -$243K – 1429
2025
Q2 		$243K Buy
+1,894
New +$197K 0.03% 799
2023
Q3 		– Sell
-3,727
Closed -$236K – 2961
2023
Q2 		$236K Buy
+3,727
New +$203K ﹤0.01% 2064

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Securities's BPMC Position: Q3 2025 in Review

Two Sigma Securities sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,894 shares — an estimated $243K sold.

Two Sigma Securities first reported a position in BPMC in Q2 2023 and held it in 2 quarters. The position peaked at $243K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Two Sigma Securities reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,894 Blueprint Medicines shares in Q3 2025, an estimated $243K.
  • Two Sigma Securities first reported a position in Blueprint Medicines in Q2 2023 and held it in 2 quarters.
  • Two Sigma Securities's Blueprint Medicines position peaked at $243K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.